Media Inquiries

The ADDF's science team includes experts in Alzheimer's disease and related dementias, neuroscience, geriatric medicine, drug discovery, and dementia prevention. They are available for comment on breaking news stories, research trends, and other topics.

To connect with an expert on staff, please contact Krishna Knabe, Director of Communications, at 212.901.7997.

Media Releases

May 15, 2017

$2.6 Million in New Grants Spurs Innovation

May 11, 2017

Tad Smith & Sotheby's Honored at Connoisseur's Dinner

April 27, 2017

Author Sally Quinn Honored at Our Great Ladies Luncheon, Hosted by Judy Woodruff

April 24, 2017

ADDF Invests $300,000 to Support Phase 2 Clinical Trial of Epigenetic Therapy

April 20, 2017

ADDF-Funded Scientists Discover Two Repurposed Drugs With Promise for Alzheimer's and FTD

April 13, 2017

ADDF Funding Advances M3 Biotechnology Toward Clinical Trials

Print